Streptococcus pneumoniae worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 670-683

  Dénes, Ádám ^a,b   Pradillo, Jesus M ^a   Drake, Caroline ^a   Sharp, Andrew ^c   Warn, Peter ^c   Murray, Katie N ^a   Rohit, Bazaz ^d   Dockrell, David H ^d   Chamberlain, Janet ^d   Casbolt, Helen ^d   Francis, Sheila ^d   Martinecz, Bernadett ^b   Nieswandt, Bernhard ^e   Rothwell, Nancy J ^a   Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IB ALPHA; INTERLEUKIN 1;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIUM ISOLATION; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMORBIDITY; DISEASE EXACERBATION; FUNCTIONAL DISEASE; GRANULOCYTOSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULARIZATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIA; THROMBOCYTE ACTIVATION;

ANIMALS; BRAIN ISCHEMIA; DISEASE PROGRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RATS; RATS, WISTAR; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84902256480     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24146     Document Type: Article

References (43)

1. Marrie TJ,. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000; 31: 1066-1078.
2. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374: 893-902.
3. Marrie TJ,. Community-acquired pneumonia. Clin Infect Dis 1994; 18: 501-513; quiz 514-515.
4. Denes A, Pinteaux E, Rothwell NJ, Allan SM,. Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target. Cerebrovasc Dis 2012; 32: 517-527.
5. Emsley HC, Hopkins SJ,. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7: 341-353.
6. Marijon E, Mirabel M, Celermajer DS, Jouven X,. Rheumatic heart disease. Lancet 2012; 379: 953-964.
7. Musher DM, Rueda AM, Kaka AS, Mapara SM,. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007; 45: 158-165.
8. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618.
9. Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, et al. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. BMC Public Health 2012; 12: 222.
10. Tseng HF, Slezak JM, Quinn VP, et al. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010; 303: 1699-1706.
11. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9: 736-743.
12. Ott SJ, El Mokhtari NE, Musfeldt M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113: 929-937.
13. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736.
14. Prass K, Braun JS, Dirnagl U, et al. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006; 37: 2607-2612.
15. Mangat R, Su J, Scott PG, et al. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome. Biochem Soc Trans 2007; 35: 477-481.
16. Denes A, Humphreys N, Lane TE, et al. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J Neurosci 2010; 30: 10086-10095.
17. Pradillo JM, Denes A, Greenhalgh AD, et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J Cereb Blood Flow Metab 2012; 32: 1810-1819.
18. Kleinschnitz C, Pozgajova M, Pham M, et al. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007; 115: 2323-2330.
19. Chapman KZ, Dale VQ, Denes A, et al. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 1764-1768.
20. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476.
21. Madrigal JL, Caso JR, de Cristobal J, et al. Effect of subacute and chronic immobilisation stress on the outcome of permanent focal cerebral ischaemia in rats. Brain Res 2003; 979: 137-145.
22. Drake C, Boutin H, Jones MS, et al. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 2011; 25: 1113-1122.
23. Denes A, Drake C, Stordy J, et al. Interleukin-1 mediates neuroinflammatory changes associated with diet-induced atherosclerosis. J Am Heart Assoc 2012; 1: e002006.
24. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (suppl 3): iii1-iii55.
25. Henriques-Normark B, Normark S,. Commensal pathogens, with a focus on Streptococcus pneumoniae, and interactions with the human host. Exp Cell Res 2010; 316: 1408-1414.
26. Kadioglu A, Andrew PW,. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004; 25: 143-149.
27. Koppe U, Suttorp N, Opitz B,. Recognition of Streptococcus pneumoniae by the innate immune system. Cell Microbiol 2012; 14: 460-466.
28. Iadecola C, Anrather J,. The immunology of stroke: from mechanisms to translation. Nat Med 2012; 17: 796-808.
29. Denes A, Thornton P, Rothwell NJ, Allan SM,. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2011; 24: 708-723.
30. McColl BW, Rothwell NJ, Allan SM,. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci 2007; 27: 4403-4412.
31. Ezzahiri R, Stassen FR, Kurvers HA, et al. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur J Vasc Endovasc Surg 2003; 26: 88-95.
32. Stassen FR, Vainas T, Bruggeman CA,. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 2008; 60: 85-92.
33. Kronenberg A, Zucs P, Droz S, Muhlemann K,. Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004. J Clin Microbiol 2006; 44: 2032-2038.
34. Andonegui G, Goring K, Liu D, et al. Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: an experimental mouse model of gram-positive sepsis. Shock 2009; 31: 423-428.
35. Grau AJ, Buggle F, Becher H, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology 1998; 50: 196-203.
36. Grau AJ, Buggle F, Heindl S, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995; 26: 373-379.
37. Muhammad S, Haasbach E, Kotchourko M, et al. Influenza virus infection aggravates stroke outcome. Stroke 2011; 42: 783-791.
38. McNicol A, Israels SJ,. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol 2010; 88: 510-524.
39. Allen C, Thornton P, Denes A, et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol 2012; 189: 381-392.
40. Denes A, Ferenczi S, Kovacs KJ,. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation 2011; 8: 164.
41. Keane C, Tilley D, Cunningham A, et al. Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2. J Thromb Haemost 2012; 8: 2757-2765.
42. Thornton P, McColl BW, Greenhalgh A, et al. Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 2010; 115: 3632-3639.
43. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-583.